Health & Safety Industry Today
Nuclear Medicine Therapeutics Market Set for Strong Performance, Expected to Achieve USD 8.7 Billion by 2035
WiseGuy Reports, Oct. 2025 (Press Release) – The Nuclear Medicine Therapeutics Market Global Outlook:
Global Nuclear Medicine Therapeutics Market Growth Analysis and Trends Report Application (Oncology, Cardiology, Neurology, Thyroid Disorders), By Radioisotope Type (Iodine-131, Strontium-89, Yttrium-90, Radium-223), By End User (Hospitals, Diagnostic Centers, Research Laboratories, Specialty Clinics) and By Regions - Global Industry Forecast 2025 to 2035
Nuclear Medicine Therapeutics Market Overview
The Nuclear Medicine Therapeutics Market is gaining strong momentum as the healthcare industry accelerates toward precision and personalized treatment approaches. Valued at USD 4.66 billion in 2024, the market is projected to reach USD 8.7 billion by 2035, expanding at a CAGR of 5.9% between 2025 and 2035. This growth trajectory reflects the rising adoption of radiopharmaceuticals for oncology, cardiology, and neurology applications, coupled with continuous innovations in targeted drug delivery and diagnostic imaging systems.
Market Overview
Nuclear medicine therapeutics involves the use of radioactive substances for the diagnosis and treatment of diseases such as cancer and cardiovascular disorders. The increasing burden of chronic diseases and the global shift toward minimally invasive, targeted therapies are propelling market expansion. The availability of favorable regulatory frameworks in North America and Europe, alongside supportive government initiatives promoting the use of nuclear medicine, is further strengthening industry growth.
According to the latest market data, the Nuclear Medicine Therapeutics Market recorded USD 4.94 billion in 2025, and with ongoing advancements in diagnostic imaging modalities, the market is expected to deliver consistent year-over-year growth through 2035.
Request To Free Sample of This Strategic Report: https://www.wiseguyreports.com/sample-request?id=735522
Key Growth Drivers
The Nuclear Medicine Therapeutics Market is influenced by several dynamic growth factors that are reshaping treatment paradigms across oncology and cardiovascular medicine.
The increasing prevalence of cancer worldwide remains the leading demand driver. Radiopharmaceutical therapies, such as radioligand and peptide receptor radionuclide therapies (PRRT), are proving effective in treating complex malignancies.
Technological advancements in radioisotope production and imaging modalities have enabled faster and more accurate disease diagnosis.
Growing demand for targeted therapies is fueling research collaborations between pharmaceutical manufacturers and nuclear medicine companies.
The rising prevalence of cardiovascular diseases has also increased the adoption of nuclear medicine techniques like myocardial perfusion imaging.
Moreover, the favorable regulatory environment across major healthcare markets has facilitated faster approval and commercialization of next-generation nuclear therapeutics.
Regional Analysis
The Nuclear Medicine Therapeutics Market exhibits strong geographic diversity across North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA).
North America dominates the market, driven by the presence of established players such as Cardinal Health, Lantheus Medical Imaging, and General Electric. The U.S. accounts for the majority of regional demand, supported by robust healthcare infrastructure and early adoption of innovative treatments.
Europe follows closely, with Germany, the U.K., and France at the forefront of radiopharmaceutical development and clinical adoption. Increasing cancer screening programs and government-backed nuclear medicine research initiatives are key growth factors in this region.
Asia-Pacific is emerging as the fastest-growing regional market, led by China, Japan, and India. Rising healthcare expenditure, expanding diagnostic imaging facilities, and local radioisotope production capacity are enhancing accessibility to nuclear therapies.
South America and MEA regions are witnessing gradual adoption supported by public health initiatives and collaborations with global medical technology companies.
Segmentation Insights
The Nuclear Medicine Therapeutics Market is segmented by Application, Radioisotope Type, End User, and Region.
By Application, oncology remains the dominant segment, with radiopharmaceuticals used in prostate cancer, neuroendocrine tumors, and thyroid cancer. The cardiology segment is also gaining momentum due to increased cases of coronary artery disease.
By Radioisotope Type, beta emitters and alpha emitters are the most utilized isotopes for targeted radiotherapy, while gamma emitters are primarily used for imaging and diagnostics.
By End User, hospitals and specialty clinics represent the largest share due to the availability of advanced imaging technologies and trained professionals. Diagnostic centers are also expanding their use of nuclear medicine procedures to improve accuracy and patient outcomes.
You Can Purchase Complete Report: https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=735522
Competitive Landscape
The Nuclear Medicine Therapeutics Market is highly competitive, with leading companies focusing on innovation, mergers, and partnerships to expand their portfolios. Key players include Sandoz, IAmChemistry, Thermo Fisher Scientific, NorthStar Medical Radioisotopes, Lantheus Medical Imaging, Elekta, Curium Pharma, United Imaging Healthcare, Bayer, Bristol Myers Squibb, Novartis, Cardinal Health, General Electric, Draximage, and Siemens Healthineers.
These companies are investing heavily in radiopharmaceutical research and radioisotope production technologies to enhance therapeutic precision and efficiency. Collaborations between healthcare institutions and technology developers are expected to shape the competitive landscape over the forecast period.
Key Market Opportunities
The future outlook for the Nuclear Medicine Therapeutics Market is promising, supported by strong R&D investments and expanding applications of nuclear medicine beyond oncology. Opportunities include:
- Growing demand for targeted radiotherapies for advanced-stage cancers
- Advances in radiopharmaceutical technology, improving safety and effectiveness
- Expansion of diagnostic imaging modalities such as PET and SPECT scanners
- Increased investment in nuclear medicine research and isotope production
- Rising collaboration between academic research centers and pharmaceutical firms
Reasons To Buy The Nuclear Medicine Therapeutics Market Report:
➼ In-depth analysis of the Nuclear Medicine Therapeutics Market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods
Other Related Reports from Latest WiseGuy Reports:
Laboratory Supplies Labware Market
Linezolid Glucose Injection Market
Medical Baby Care Equipment Market
Medical Biological Sensors Market
Laryngoscope Blade Handle Market
About US:
Wise Guy Reports is pleased to introduce itself as a leading provider of insightful market research solutions that adapt to the ever-changing demands of businesses around the globe. We want our clients to have information that can be used to act upon their strategic initiatives. We, therefore, aim to be your trustworthy partner within dynamic business settings through excellence and innovation. By offering comprehensive market intelligence, our company enables corporate organizations to make informed choices, drive growth, and stay ahead in competitive markets
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
